Molecular characterization of HERV-H variants associated with multiple sclerosis

Acta Neurologica Scandinavica

Volumn 101, Issue 4, 2000, Pages 229-238

  Christensen, T ^a   Dissing Sorensen P ^b   Riemann, H ^b   Hansen, H J ^c   Munch, M ^a   Haahr, S ^a   Moller Larsen A ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b Biotechnological Institute Denmark   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Endogenous retrovirus; Expression; HERV H; Multiple sclerosis; RGH; Virions

Indexed keywords

NUCLEIC ACID BINDING PROTEIN; NUCLEOCAPSID PROTEIN; PHYTOHEMAGGLUTININ;

ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOBLAST; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; RETROVIRUS; SEQUENCE HOMOLOGY; VIRION; VIRUS CHARACTERIZATION; VIRUS PARTICLE; VIRUS TRANSMISSION;

EID: 0034110441     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2000.101004229.x     Document Type: Article

References (48)

1. 1. Martyn C. The epidemiology of multiple sclerosis. In: Matthews WB, ed. McAlpines's Multiple Sclerosis. Edinburgh: Churchill Livingstone, 1991:3-40.
2. 2. Christensen T, Møller-Larsen A, Haahr S. A retroviral implication in multiple sclerosis? Trends Microbiol 1994;9: 332-6.
3. 3. Haahr S, Munch M, Christensen T, Møller-Larsen A, Hvas J. Cluster of multiple sclerosis patients from Danish community. The Lancet 1997;341:923.
4. 4. Haahr S, Sommerlund M, Møller-Larsen A, Nielsen R, Hansen HJ. Just another dubious virus in cells from a patient with multiple sclerosis? The Lancet 1991;i:863.
5. 5. Sommerlund M, Pallesen G, Møller-Larsen A, Hansen HJ, Haahr S. Retrovirus-like particles in an Epstein-Barr virus-producing cell line derived from a patient with chronic progressive myelopathy. Acta Neurol Scand 1993;87:71-6.
6. 6. Munch M, Møller-Larsen A, Christensen T, Morling N, Hansen HJ, Haahr S. B-lymphoblastoid cell lines established from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein Barr virus. Multiple Sclerosis 1995;1:78-81.
7. 7. Christensen T, Jensen AW, Munch M et al. Characterization of retrovirus from multiple sclerosis patients. Acta Neurol Scand 1997;Suppl 169:49-58.
8. 8. Christensen T, Tönjes RR, zur Megede J, Boller K, Møller-Larsen A. RT Activity and Particle Production in B-lymphoblastoid Cell Lines from lymphocytes from multiple sclerosis patients. AIDS Res Hum Retroviruses 1999;15: 285-91.
9. 9. Christensen T, DissingSørensen P, Riemann H, Hansen HJ, Møller-Larsen A. Expression of the Endogenous Retrovirus RGH in Particle Form in Multiple Sclerosis. The Lancet 1998;352:1033.
10. 10. Boller K, Janssen O, Schuldes H, Tönjes RR, Kurth R. Characterization of the antibody response specific for the human endogenous retrovirus HTDV/HERV-K. J Virol 1997;71:4581-8.
11. 11. Tönjes RR, Löwer R, Boller K et al. HERV-K: The biologically most active human endogenous retrovirus family. J Acq Imm Def Syndr Hum Retrovirol 1996;13: S261-7.
12. 12. Perron H, Garson JA, Bedin F et al. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. Proc Natl Acad Sci 1997;94:7583-8.
13. 13. Garson JA, Tuke PW, Giraud P, Paranhos-Baccala G, Perron H. Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis. The Lancet 1998; 351:33.
14. 14. Komurian-Pradel F, Paranhos-Baccala G, Bedin F et al. Molecular cloning and characterization of MSRV-related sequences associated with retrovirus-like particles. Virology 1999;260:1-9.
15. 15. Conrad B, Weissmahr RN, Böni J, Arcari R, Schüpbach J, Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type 1 diabetes. Cell 1997; 90:303-13.
16. 16. Møller-Larsen A, Christensen T. Isolation of a retrovirus from multiple sclerosis patients in self-generated Iodixanol Gradients. J Virol Methods 1998;73:151-61.
17. 17. Lugert R, König H, Kurth R, Tönjes RR. Specific suppression of false positive signals in the Product Enhanced Reverse Transcriptase assay. Biotechniques 1996; 20:210-17.
18. 18. Silver J, Maudru T, Fujita K, Repaske R. An RT-PCR assay for the enzyme activity of reverse transcriptase capable of detecting single virions. Nucl Acids Res 1993; 21:3593-4.
19. 19. Pyra H, Böni J, Schüpbach J. Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. Proc Natl Acad Sci 1994;91:1544-8.
20. 20. Medstrand P, Lindeskog M, Blomberg J. Expression of human endogenous retroviral sequences in peripheral blood mononuclear cells of healthy individuals. J Gen Virol 1992; 73:2463-6.
21. 21. Hirose Y, Takamatsu M, Harada F. Presence of env genes in members of the RTVL-H family of human endogenous retrovirus-like elements. Virology 1993;192:52-61.
22. 22. Linial ML, Miller AD. Retroviral RNA packaging: sequence requirements and implications. Curr Top Microbiol Immunol 1990;157:125-52.
23. 23. Mager DL, Freeman JD. Human endogenous retrovirus-like genome with type C pol sequences and gag sequences related to human T-cell lymphotropic virus. J Virol 1987; 61:4060-7.
24. 24. Morozov VA, Lagaye S, Ilyinski PO, Cherepovsky DN, Ilyin K. Analyses of retroviral proteins by two-step DNA, zinc binding and modified South-Western blotting. Intervirology 1992;34:117-23.
25. 25. DeRossi A, Aldovini A, Franchini G, Mann D, Gallo RC, Wong-Staal F. Clonal selection of T lymphocytes infected by cell-free human T cell leukemia/lymphotropic virus type 1. Parameters of virus integration and expression. Virology 1985;143:640-5.
26. 26. Hohenadl C, Leib-Mösch C, Hehlmann R, Erfle V. Biological significance of human endogenous retroviral sequences. J Acquired Immune Defic Syndr Hum Retrovirol 1996; Suppl 1:5268-73.
27. 27. Markham PD, Ruscetti F, Salahuddin SZ, Gallagher RE, Gallo RC. Enhanced induction of growth of B lymphoblasts from fresh human blood by primate type-C retroviruses (Gibbon Ape Leukemia Virus and Simian Sarcoma Virus). Int J Cancer 1979;23:148-56.
28. 28. Krieg AM, Gourley MF, Perl A. Endogenous retroviruses: potential etiologic agents in autoimmunity. FASEB J 1992;6:2537-44.
29. 29. Dalgliesh AG. Viruses and multiple sclerosis. Acta Neurol Scand 1997;Suppl 169:8-15.
30. 30. Boller K, König H, Sauter M et al. Evidence that HERV-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma derived retrovirus HTDV. Virology 1993;196:349-54.
31. 31. Wilkinson DA, Goodchild NL, Saxton TM, Wood S, Mager DL. Evidence for a functional subclass of the RTVL-H family of human endogenous retrovirus-like sequences. J Virol;67:2981-9.
32. 32. Lindeskog M, Mager DL, Blomberg J. Isolation of a human endogenous retroviral HERV-H element with an open env reading frame. Virology 1999;258:441-50.
33. 33. Kelleher CA, Wilkinson DA, Freeman JD, Mager DL, Gelfand EW. Expression of novel transposon-containing mRNAs in human T cells. J Gen Virol 1996;77:1101-9.
34. 34. Löwer R, Löwer J, Tondera-Koch C, Kurth R. A general method for the identification of transcribed retrovirus sequences (R-U5 PCR) reveals the expression of the human endogenous retrovirus loci HERV-H and HERV K in teratocarcinoma cells. Virology 1993;192:501-10.
35. 35. Johansen J, Holm T, Bjorklid E. Members of the RTVL-H family are expressed in human placenta. Gene 1989;79: 259-67.
36. 36. Goodchild NL, Wilkinson DA, Mager DL. Recent evolutionary expansion of a subfamily of RTVL-H human endogenous retrovirus-like elements. Virology 1993;196: 778-88.
37. 37. Blond JL, Beseme F, Duret L et al. Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J Virol 1999;73:1175-85.
38. 38. Griffiths DJ, Venables PJW, Weiss RA, Boyd MT. A novel exogenous retrovirus sequence identified in humans. J Virol 1997;71:2866-72.
39. 39. Yamano S, Renard JN, Mizuno F et al. Retrovirus in salivary glands from patients with Sjögren's syndrome. J Clin Pathol 1997;50:223-9.
40. 40. Bengtsson A, Blomberg J, Nived O, Pipkorn R, Toth L, Stuhrfeldt G. Selective antibody reactivity with peptides from human endogenous retroviruses and nonviral poly-(amino acids) in patients with systemic lupus erythematosus. Arthritis Rheum 1996;39:1654-63.
41. 41. Nakagawa K, Brusic V, McColl G, Harrison LC. Direct evidence for the expression of multiple endogenous retroviruses in the synovial compartment in rheumatoid arthritis. Arthritis Rheum 1997;40:627-38.
42. 42. Nielsen L, Møller-Larsen A, Munch M, Vestergaard BF. Human Herpesvirus 6 immunoglobulin G antibodies in patients with multiple sclerosis. Acta Neurol Scand 1997; Suppl 169:76-8.
43. 43. Sanders VJ, Felisan S, Waddell A, Tourtellotte WW. Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J Neurovirol 1996;2:249.
44. 44. Haahr S, Koch-Henrichsen N, Møller-Larsen A, Eriksen LS, Andersen HMK. Increased risk of multiple sclerosis after late Epstein-Barr infection: a historical prospective study. Multiple Sclerosis 1995;1:73-7.
45. 45. Challoner PB, Smith KT, Parker JD et al. Plaque associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci 1996;92:7440-4.
46. 46. Klenerman P, Hengartner H, Zinkernagel RM. A non-retroviral RNA virus persists in DNA form. Nature 1997;390:298-301.
47. 47. Bhat NK, Adachi Y, Samuel KP, Derse D. HTLV-1 gene expression by defective proviruses in an infected T-cell line. Virology 1993;196:15-24.
48. 48. Sun R, Grogan E, Shedd D et al. Transmissible retrovirus in Epstein Barr virus-producer B95-8 cells. Virology 1995;209:374-83.